Owner Novartis AG

Inventors Feldman, David Louis; Webb, Randy Lee

Agent Davies Collison Cave

Pub. Number AU-B-2003240669

PCT Number PCT/EP03/05188

PCT Pub. Number WO2003/097098

Priority 60/381,546 17.05.02 US

Filing date 16 May 2003

Wipo publication date 2 December 2003

Acceptance publication date 8 March 2007

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/192 (2006.01)

A61K 31/196 (2006.01)

A61K 31/277 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/385 (2006.01) - having two or more sulfur atoms in the same ring

A61K 31/4184 (2006.01)

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4422 (2006.01) - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine

A61K 31/4439 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 31/585 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 Drugs for disorders of the cardiovascular system